The formation of morbidity and the risk of developing hepatitis A in the population of the Russian Federation

Introduction. Outbreaks of viral hepatitis A (HAV) remain of socio-economic importance, but the role of the water factor has not been sufficiently studied, which reduces the effectiveness of prevention. The epidemic HAV potential determines the relevance of analyzing risk factors and predicting morbidity.

Purpose to study risk factors and predict the incidence of hepatitis A based on water contamination and vaccination rates in the Russian Federation.

Materials and methods. In 2014–2023, water samples (n = 170,372) were taken from sources of centralized and non-centralized water supply, surface and wastewater in 89 regions of the Russian Federation. The studies were carried out by the serological method, statistical processing was carried out using the R software.

Results. During the studied period, the average HAV contamination was: in centralized water supply — 0.09% (95% CI 0.07–0.11), non—centralized — 0.31% (95% CI 0.17–0.53), surface reservoirs — 0.14% (95% CI 0.11–0.19), wastewater — 0.41% (95% CI 0.35–0.48). There was a tendency to decrease the proportion of positive samples in non-centralized water supply (r = –0.78; p = 0.01) and wastewater (r = –0.87; p = 0.001). The incidence of HAV has a strong direct correlation with contamination of non-centralized water supply (r = 0.75; p = 0.01) and wastewater (r = 0.70; p = 0.03), as well as a moderate correlation with the vaccination rate (r = –0.69; p = 0.047). Linear regression equations reflecting the effect of morbidity on wastewater contamination and the effect of vaccination on morbidity are obtained.

Research limitations. The official data on the HAV incidence in the Russian Federation for 2014–2023 were used, which ensures a representative sample.

Conclusion. The data obtained can be used to predict the incidence of HCV, assess the associated economic damage, as well as to calculate the level of wastewater contamination for planning preventive measures.

Compliance with ethical standards. This study did not require the conclusion of the biomedical ethics committee (the study was based on publicly available official statistics).

Contribution of the authors:
Badamshina G.G. — collecting material, conducting research, analyzing literature, statistical processing, analyzing data obtained and editing;
Gafarova L.F. — conducting research, analyzing literature, statistical processing, analyzing data obtained and editing;
Poptsova E.A. — conducting research, analyzing data obtained and editing;
Trukhina G.M. — collecting material, literature analysis, data analysis and editing;
Samotoina A.A. — collecting material, conducting research and editing;
Yuzlibaeva L.R. — literature analysis, analysis of obtained data;
Malinnikova E.Yu. — article editing;
Fatkhutdinova L.M. — idea and development of the concept of the article, literature analysis, analysis of the data obtained and scientific editing of the article;
Ilyinskaya O.N. — scientific and final editing of the article.
All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.

Funding. The study had no sponsorship.

Conflict of interest. The authors declare no conflict of interest.

Received: July 28, 2025 / Accepted: February 19, 2026 / Published: April 30, 2026

1. WHO. Hepatitis A; 2025. Available at: https://who.int/news-room/fact-sheets/detail/hepatitis-a

2. Jacobsen K.H., Wiersma S.T. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010; 28(41): 6653–7. https://doi.org/10.1016/j.vaccine.2010.08.037

3. Jacobsen K.H. Globalization and the changing epidemiology of hepatitis A virus. Cold Spring Harb. Perspect. Med. 2018; 8(10): a031716. https://doi.org/10.1101/cshperspect.a031716

4. Pokrovskii V.I., Tololyan A.A., eds. Viral Hepatitis in the Russian Federation. Analytical Review. 11th Edition. St. Petersburg; 2018. https://elibrary.ru/hleeql (in Russian)

5. Mikhaylova Yu.V., Gromov A.V., Averyanova E.L., Sterlikov S.A. The dynamics of viral hepatitis morbidity in the Russian Federation in 2015–2021. Sovremennye problemy zdravookhraneniya i meditsinskoi statistiki. 2022; (4): 269–97. https://doi.org/10.24412/2312-2935-2022-4-269-297 https://elibrary.ru/dvysxb (in Russian)

6. State Report «On the State of Sanitary and Epidemiological Well-Being of the Population in the Russian Federation in 2022». Moscow; 2023. (in Russian)

7. State Report «On the State of Sanitary and Epidemiological Well-Being of the Population in the Russian Federation in 2023». Moscow; 2024. (in Russian)

8. Havelaar A.H., Kirk M.D., Torgerson P.R., Gibb H.J., Hald T., Lake R.J., et al. World Health Organization global estimates and regional comparisons of the burden of foodborne disease in 2010. PLoS Med. 2015; 12(12): e1001923. https://doi.org/10.1371/journal.pmed.1001923

9. Collier M.G., Khudyakov Y.E., Selvage D., Adams-Cameron M., Epson E., Cronquist A., et al. Outbreak of hepatitis A in the USA associated with frozen pomegranate arils imported from Turkey: an epidemiological case study. Lancet. Infect. Dis. 2014; 14(10): 976–81. https://doi.org/10.1016/s1473-3099(14)70883-7

10. Zhou F., Shefer A., Weinbaum C., McCauley M., Kong Y. Impact of hepatitis A vaccination on health care utilization in the United States, 1996–2004. Vaccine. 2007; 25(18): 3581–7. https://doi.org/10.1016/j.vaccine.2007.01.081

11. European Centre for Disease Prevention and Control (ECDC). Hepatitis A virus in the EU/EEA, 1975–2020. Stockholm; 2021. Available at: https://ecdc.europa.eu/en/publications-data/hepatitis-virus-eueea-1975-2014

12. Takuissu G.R., Kenmoe S., Ebogo-Belobo J.T., Kengne-Ndé C., Mbaga D.S., Bowo-Ngandji A., et al. Occurrence of hepatitis A virus in water matrices: a systematic review and meta-analysis. Int. J. Environ. Res. Public Health. 2023; 20(2): 1054. http://doi.org/10.3390/ijerph20021054

13. Báez P.A., Jaramillo C.M., Arismendi L., Rendón J.C., Cortés-Mancera F., Peláez D., et al. Evidence of the circulation of hepatitis A virus, subgenotype IA, in environmental samples from Antioquia, Colombia. Biomedica. 2016; 36(0): 135–47. http://doi.org/10.7705/biomedica.v36i0.2979

14. Bahk Y.Y., Kim M.H., Kim T.S., Park S.J., Kim J.M., Rhee O.J., et al. Occurrence of four waterborne viruses at five typical raw water resources in the Republic of Korea during August 2013 to February 2019. J. Microbiol. 2020; 58(11): 915–25. http://doi.org/10.1007/s12275-020-0231-0

15. Ré V.E., Ridruejo E., Fantilli A.C., Moutinho B.D., Pisano M.B., Pessoa M.G. Hepatitis A in Latin America: The current scenario. Rev. Med. Virol. 2024; 34(4): e2566. http://doi.org/10.1002/rmv.2566

16. Kuodi P., Patterson J., Silal S., Hussey G.D., Kagina B.M. Characterisation of the environmental presence of hepatitis A virus in low-income and middle-income countries: a systematic review and meta-analysis. BMJ Open. 2020; 10(9): e036407. https://doi.org/10.1136/bmjopen-2019-036407

17. Prado T., Fumian T.M., Miagostovich M.P., Gaspar A.M. Monitoring the hepatitis A virus in urban wastewater from Rio de Janeiro, Brazil. Trans. R. Soc. Trop. Med. Hyg. 2012; 106(2): 104–9. https://doi.org/10.1016/j.trstmh.2011.10.005

18. Aw T.G., Gin K.Y. Environmental surveillance and molecular characterization of human enteric viruses in tropical urban wastewaters. J. Appl. Microbiol. 2010; 109(2): 716–30. https://doi.org/10.1111/j.1365-2672.2010.04701.x

19. Adefisoye M.A., Nwodo U.U., Green E., Okoh A.I. Quantitative PCR detection and characterisation of human adenovirus, rotavirus and hepatitis A virus in discharged effluents of two wastewater treatment facilities in the Eastern Cape, South Africa. Food Environ. Virol. 2016; 8(4): 262–74. http://doi.org/10.1007/s12560-016-9246-4

20. Hamza H., Abd-Elshafy D.N., Fayed S.A., Bahgat M.M., El-Esnawy N.A., Abdel-Mobdy E. Detection and characterization of hepatitis A virus circulating in Egypt. Arch. Virol. 2017; 162(7): 1921–31. https://doi.org/10.1007/s00705-017-3294-4

21. Lo Castro I., Espul C., de Paula V.S., Altabert N.R., Gonzalez J.E., Lago B.V., et al. High prevalence of hepatitis A and E viruses in environmental and clinical samples from West Argentina. Braz. J. Infect. Dis. 2023; 27(2): 102738. https://doi.org/10.1016/j.bjid.2022.102738

22. Raya S., Tandukar S., Kattel H.P., Sharma S., Sangsanont J., Sirikanchana K., et al. Prevalence of hepatitis A and E viruses in wastewater in Asian countries. Sci. Total. Environ. 2024; 951: 175473. https://doi.org/10.1016/j.scitotenv.2024.175473

23. Chulanov V.P., Shipulin G.A., Shipulina O.Yu., Volchkova E.V., Pak S.G., Pokrovsky V.V. Polymerase chain reaction in diagnostics of viral hepatitis. Infektsionnye bolezni. 2003; 1(1): 43–8. https://elibrary.ru/iadcqp (in Russian)

24. Carrillo-Santisteve P., Tavoschi L., Severi E., Bonfigli S., Edelstein M., Byström E., et al. Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review. Lancet Infect. Dis. 2017; 17(10): e306–19. https://doi.org/10.1016/S1473-3099(17)30392-4